1. Capital expenditure by our Company for opening new dialysis clinics in India and;2. Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company; and 3. General corporate purposes.
We offer comprehensive dialysis care through our network of clinics – from diagnosis to treatment and wellnessprograms including haemodialysis, home and mobile dialysis, supported...
NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "
Source:
1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22